Episode 37: Clinical Conversations: Anti-Obesity Medicines Under Development

In this episode, obesity medicine specialist and OMA Clinical Education Director, Nicholas Pennings, DO, FOMA, Dipl. ABOM interviews Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC, a highlighted speaker from Overcoming Obesity 2020 – Virtual, about new pharmaceutical agents in development to treat obesity. Topics covered include why anti-obesity medicines may be necessary in treatment, treatment targets and efficacy of newer pharmaceutical agents, role of combination medications in treatment, and a discussion about stigma and bias around anti-obesity medications.

You can access more information about Obesity Medicine podcasts and other resources from the clinical leader in Obesity Medicine at www.obesitymedicine.org/podcasts.

Episode Guests

Nicholas Pennings, DO, FOMA, Dipl. ABOM

Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC

Resources Mentioned

Anti-Obesity Medications in the Pipeline Lecture